Overslaan en naar de inhoud gaan

 Alle verbonden artikelen

Feasibility of developing reliable gene expression modules from FFPE derived RNA profiled on Affymetrix arrays.

Auteurs : Jose V, Fumagalli D, Rothé F, Majjaj S, Loi S, Michiels S, Sotiriou C
Jaar : 2018
Journal : PLoS One
Volume : 13
Pagina's : e0203346

Scoring of tumor-infiltrating lymphocytes: From visual estimation to machine learning.

Auteurs : Klauschen F, Müller KR, Binder A, Bockmayr M, Hägele M, Seegerer P, Wienert S, Pruneri G, de Maria S, Badve S, Michiels S, Nielsen TO, Adams S, Savas P, Symmans F, Willis S, Gruosso T, Park M, Haibe-Kains B, Gallas B, Thompson AM, Cree I, Sotiriou C, Solinas C, Preusser M, Hewitt SM, Rimm D, Viale G, Loi S, Loibl S, Salgado R, Denkert C
Jaar : 2018
Journal : Semin Cancer Biol
Volume : 52
Pagina's : 151-157

The light chain IgLV3-21 defines a new poor prognostic subgroup in Chronic Lymphocytic Leukemia: results of a multicenter study.

Auteurs : Stamatopoulos B, Smith T, Crompot E, Pieters K, Clifford R, Mraz M, Robbe P, Burns A, Timbs A, Bruce DR, Hillmen P, Meuleman N, Mineur P, Firescu R, Maerevoet M, de Wilde V, Efira AA, Philippé J, Verhasselt B, Offner F, Sims D, Heger A, Dreau H, Schuh A
Jaar : 2018
Journal : Clin Cancer Res
Volume : 24(20)
Pagina's : 5048-5057

Diagnostic approach of an IgM monoclonal gammopathy and clinical importance of gene MYD88 L265P mutation.

Auteurs : Cilla N, Vercruyssen M, Ameye L, Paesmans M, de Wind A, Heimann P, Meuleman N, Bron D
Jaar : 2018
Journal : Rev Med Brux

Adherence to geriatric assessment-based recommendations in older patients with cancer: a multicenter prospective cohort study in Belgium.

Auteurs : Kenis C, Decoster L, Flamaing J, Debruyne PR, De Groof I, Focan C, Cornélis F, Verschaeve V, Bachmann C, Bron D, Luce S, Debugne G, Van den Bulck H, Goeminne JC, Schrijvers D, Geboers K, Petit B, Langenaeken C, Van Rijswijk R, Specenier P, Jerusalem G, Praet JP, Vandenborre K, Lobelle JP, Lycke M, Milisen K, Wildiers H
Jaar : 2018
Journal : Ann Oncol
Volume : 29
Pagina's : 1987-1994

Efficacy of chemotherapy or chemo-anti-PD-1 combination after failed anti-PD-1 therapy for relapsed and refractory Hodgkin lymphoma: A series from Lysa centers.

Auteurs : Rossi C, Gilhodes J, Maerevoet M, Herbaux C, Morschhauser F, Brice P, Garciaz S, Borel C, Ysebaert L, Obéric L, Lazarovici J, Deau B, Dupuis J, Chauchet A, Abraham J, Bijou F, Stamatoullas-Bastard A, Malfuson JV, Golfier C, Laurent C, Pericart S, Traverse-Glehen A, Kanoun S, Filleron T, Casasnovas RO, Ghesquières H
Jaar : 2018
Journal : Am J Hematol

Are we ready for intercultural cancer care?

Auteurs : Crombez P, Michiels S, Bron D
Jaar : 2018
Journal : Curr Opin Oncol
Volume : 30(4)
Pagina's : 205-211

Reducing mortality in newly diagnosed standard-risk acute promyelocytic leukemia in elderly patients treated with arsenic trioxide requires major reduction of chemotherapy: a report by the French Belgian Swiss APL group (APL 2006 trial).

Auteurs : Rahmé R, Ades L, Thomas X, Guerci-Bresler A, Pigneux A, Vey N, Raffoux E, Castaigne S, Spertini O, Wittnebel S, Marolleau JP, Damaj G, Bordessoule D, Lejeune J, Chevret S, Fenaux P
Jaar : 2018
Journal : Haematologica
Volume : 103
Pagina's : e519-e521

Impact of lenalidomide maintenance on the immune environment of multiple myeloma patients with low tumor burden after autologous stem cell transplantation.

Auteurs : Fostier K, Caers J, Meuleman N, Broos K, Corthals J, Thielemans K, Schots R, De Keersmaecker B
Jaar : 2018
Journal : Oncotarget
Volume : 9
Pagina's : 20476-20489

Long-term follow-up of 2 patients treated with 90Y-rituximab radioimmunotherapy for relapse of nodular lymphocyte-predominant Hodgkin lymphoma.

Auteurs : Golstein SC, Muylle K, Vercruyssen M, Spilleboudt C, de Wind A, Bron D
Jaar : 2018
Journal : Eur J Haematol
Volume : 101
Pagina's : 415-417

Circulating Tumor Cells in Breast Cancer Patients Treated by Neoadjuvant Chemotherapy: A Meta-analysis.

Auteurs : Bidard FC, Michiels S, Riethdorf S, Mueller V, Esserman LJ, Lucci A, Naume B, Horiguchi J, Gisbert-Criado R, Sleijfer S, Toi M, Garcia-Saenz JA, Hartkopf A, Generali D, Rothé F, Smerage J, Muinelo-Romay L, Stebbing J, Viens P, Magbanua MJM, Hall CS, Engebraaten O, Takata D, Vidal-Martínez J, Onstenk W, Fujisawa N, Diaz-Rubio E, Taran FA, Cappelletti MR, Ignatiadis M, Proudhon C, Wolf DM, Bauldry JB, Borgen E, Nagaoka R, Carañana V, Kraan J, Maestro M, Brucker SY, Weber K, Reyal F, Amara D, Karhade MG, Mathiesen RR, Tokiniwa H, Llombart-Cussac A, Meddis A, Blanche P, dHollander K, Pantel K
Jaar : 2018
Journal : J Natl Cancer Inst
Volume : 110(6)
Pagina's : 560-567

Dual JAK1 and STAT3 mutations in a breast implant-associated anaplastic large cell lymphoma.

Auteurs : Letourneau A, Maerevoet M, Milowich D, de Wind R, Bisig B, Missiaglia E, de Leval L
Jaar : 2018
Journal : Virchows Arch
Volume : 473
Pagina's : 505-511

Advanced Glycation End-Products-, C-Type Lectin- and Cysteinyl/ Leukotriene-Receptors in Distinct Mesenchymal Stromal Cell Populations: Differential Transcriptional Profiles in Response to Inflammation.

Auteurs : Najar M, Fayyad-Kazan M, Raicevic G, Fayyad-Kazan H, Meuleman N, Bron D, Lagneaux L
Jaar : 2018
Journal : Cell J
Volume : 20
Pagina's : 250-258

Intraocular T-cell Lymphoma: Clinical Presentation, Diagnosis, Treatment, and Outcome.

Auteurs : Chaput F, Amer R, Baglivo E, Touitou V, Kozyreff A, Bron D, Bodaghi B, LeHoang P, Bergstrom C, Grossniklaus HE, Chan CC, Peer J, Caspers LE
Jaar : 2017
Journal : Ocul Immunol Inflamm
Volume : 25(5)
Pagina's : 639-648

New therapeutic approaches in cutaneous T-cell lymphomas

Auteurs : Bron D, Springael C, Maerevoet M, De Vicq M, Kolivras A
Jaar : 2017
Journal : Belgian J Hematology
Volume : 8
Pagina's : 102-6

Study of the microRNA expression profile of foreskin derived mesenchymal stromal cells following inflammation priming.

Auteurs : Fayyad-Kazan H, Fayyad-Kazan M, Badran B, Bron D, Lagneaux L, Najar M
Jaar : 2017
Journal : J Transl Med
Volume : 15
Pagina's : 10

A phase III randomized trial comparing Inolimomab vs. usual care in steroid-resistant acute GVHD.

Auteurs : Socié G, Vigouroux S, Yakoub-Agha I, Bay JO, Fürst S, Bilger K, Suarez F, Michallet M, Bron D, Gard P, Medeghri Z, Lehert P, Lai C, Corn T, Vernant JP
Jaar : 2017
Journal : Blood
Volume : 129(5)
Pagina's : 643-9

Factors associated with self-perceived burden to the primary caregiver in older patients with hematologic malignancies: an exploratory study.

Auteurs : Libert Y, Borghgraef C, Beguin Y, Delvaux N, Devos M, Doyen C, Dubruille S, Etienne AM, Liénard A, Merckaert I, Reynaert C, Slachmuylder JL, Straetmans N, Neste EV, Bron D, Razavi D
Jaar : 2017
Journal : Psychooncology
Volume : 26(1)
Pagina's : 118-24

Tumour-infiltrating lymphocytes in advanced HER2-positive breast cancer treated with pertuzumab or placebo in addition to trastuzumab and docetaxel: a retrospective analysis of the CLEOPATRA study.

Auteurs : Luen SJ, Salgado R, Fox S, Savas P, Eng-Wong J, Clark E, Kiermaier A, Swain SM, Baselga J, Michiels S, Loi S
Jaar : 2017
Journal : Lancet Oncol
Volume : 18(1)
Pagina's : 52-62

Reply to M. Lambertini et al.

Auteurs : Demeestere I, Brice P, Peccatori FA, Kentos A, Dupuis J, Zachee P, Casasnovas RO, Van Den Neste E, Dechene J, De Maertelaer V, Bron D, Englert Y
Jaar : 2017
Journal : J Clin Oncol
Volume : 35(7)
Pagina's : 805-6